Clinical and Experimental Medicine

Springer Science+Business Media

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Clinical and Experimental Medicine is a journal published by Springer Science+Business Media in Italy. It is listed in MEDLINE according to the sources read. Declared publication charge: 4,590 EUR. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Springer Science+Business Media
ISSN
1591-8890 · 1591-9528
Country
Italy
Access
Not open access / not declared
Declared publication charge
4,590 EUR
Declared peer-review model
peer_review

Index listings

  • MEDLINE · 2001-01-01
Indexing
MEDLINE
APC
4,590 EUR
Declared review time (DOAJ)
—
Actual review time (measured)
89 days received→accepted — computed from PubMed (n=95)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Works in OpenAlex

4395

Last recorded publication year

2026

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

75

i10-index

1408

From OpenAlex open data (CC0).

Editorial & policy6
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Editorial board
Official page ↗
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
92%
ORCID iDs in current deposits
23%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
Identity & continuity2
Source type
journal
NLM unique ID (PubMed)
100973405
Classification(no data)

No data available to the platform for this group

No platform data for: Classification — absence is not a judgment about the journal.

Subject areas

  • Biomedical and Chemical Research
  • Biomedical and Chemical Research
  • Ferroptosis and cancer prognosis
  • Ferroptosis and cancer prognosis
  • Immune Cell Function and Interaction
  • Immune Cell Function and Interaction
  • Cancer Immunotherapy and Biomarkers
  • Cancer Immunotherapy and Biomarkers
Show all subjects (50)
  • Liver Disease Diagnosis and Treatment
  • Liver Disease Diagnosis and Treatment
  • Systemic Lupus Erythematosus Research
  • Cancer-related molecular mechanisms research
  • Cancer-related molecular mechanisms research
  • Systemic Lupus Erythematosus Research
  • Metabolism and Genetic Disorders
  • Metabolism and Genetic Disorders
  • Diet and metabolism studies
  • Lymphoma Diagnosis and Treatment
  • Diet and metabolism studies
  • Lymphoma Diagnosis and Treatment
  • RNA modifications and cancer
  • Renal function and acid-base balance
  • Renal function and acid-base balance
  • Erythrocyte Function and Pathophysiology
  • Erythrocyte Function and Pathophysiology
  • RNA modifications and cancer
  • COVID-19 Clinical Research Studies
  • COVID-19 Clinical Research Studies
  • Acute Myeloid Leukemia Research
  • MicroRNA in disease regulation
  • MicroRNA in disease regulation
  • Acute Myeloid Leukemia Research
  • Diabetes and associated disorders
  • Diabetes and associated disorders
  • T-cell and B-cell Immunology
  • Multiple Myeloma Research and Treatments
  • T-cell and B-cell Immunology
  • Multiple Myeloma Research and Treatments
  • Immunotherapy and Immune Responses
  • CAR-T cell therapy research
  • Immune Response and Inflammation
  • Immune Response and Inflammation
  • Immunotherapy and Immune Responses
  • CAR-T cell therapy research
  • Epigenetics and DNA Methylation
  • Immune cells in cancer
  • Epigenetics and DNA Methylation
  • Immune cells in cancer
  • Chronic Lymphocytic Leukemia Research
  • Chronic Lymphocytic Leukemia Research

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: